Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$4.41 USD
+0.01 (0.23%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.42 +0.01 (0.23%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HUMA 4.41 +0.01(0.23%)
Will HUMA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for HUMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HUMA
Should You Buy Humacyte (HUMA) Ahead of Earnings?
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma
HUMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Affimed N.V. (AFMD) Reports Q2 Loss, Misses Revenue Estimates
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q2 Loss, Tops Revenue Estimates
Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates
Other News for HUMA
OPI, RVNC and AQST are among after hour movers
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
Commit To Buy Humacyte At $2.50, Earn 42.4% Annualized Using Options
Tommy Tuberville Trades Raise Eyebrows Again: Senator Sells Put Options, Buys Small Biotech Linked To Ukraine-Russia War